Both in Pharmaceuticals
ProMIS Neurosciences Inc. Common Shares (ON) vs Anixa Biosciences
Over the past year PMN returned −3.3% and ANIX returned −16.4%; their daily moves had a correlation of 0.10.
PMN −3.3% ANIX −16.4%Growth of $1, one year, split-adjusted
| Metric | PMN | ANIX |
|---|---|---|
| Price | $10.64 | $2.85 |
| Market cap | $95.4M | $99.1M |
| Today | −0.14% | +2.15% |
| 1 month | −22.9% | −18.1% |
| 6 months | −17.4% | +14.0% |
| Year to date | +55.8% | −8.7% |
| 1 year | +4.1% | −16.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $53.5M | $13.9M |
| Dividend yield | — | — |
| Volatility (60d) | 90.4% | 55.8% |
| Short % of float | 3.2% | 4.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).